Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:32 AM
Ignite Modification Date:
2025-12-25 @ 1:32 AM
NCT ID:
NCT07147894
Eligibility Criteria:
Inclusion Criteria:
* 12-17 years old.
* Child must have a caregiver (parent/guardian) who is available to participate as a training aide.
* Child and parent/caregiver are able to understand/speak adequate English or Spanish to follow and participate in study procedures
* Both child and parent/guardian are willing to give informed consent/assent, be randomized to either intervention condition, and be willing to follow the assigned study protocol.
* \~50% of the participants: Meet criteria for ADHD DSM-5 diagnosis.
Exclusion Criteria:
* Child is taking ADHD medication/stimulants.
* Child has been formally identified as intellectually disabled.
* Abnormal visual acuity or hearing challenges that are prohibitive to participating in the intervention/assessment.
* History of organic mental disorders (conditions or disturbances that may be caused by injuries and/or neurodegenerative diseases affecting brain tissues), psychosis, history of autism spectrum disorders, intellectual disability, or active substance use or suicidal ideation (such individuals will be referred to psychiatric services).
* Major sensory or motor impairment that would preclude valid cognitive testing.
* Participants with color blindness, if they are unable to discriminate the task relevant stimuli.
* Populations considered vulnerable such as wards and those with neurological or other health conditions that may prevent the ability to give informed consent.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
12 Years
Maximum Age:
17 Years
Study:
NCT07147894
Study Brief:
Protocol Section:
NCT07147894